[1]
C. J. Gillis, “The value of magnetic resonance imaging-ultrasound fusion targeted biopsies for clinical decision-making among patients with previously negative transrectal ultrasound biopsy and persistent prostate-specific antigen elevation”, CUAJ, vol. 16, no. 6, pp. E315–20, Jan. 2022.